4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-004779
10% owner bought 12,551 shares at an average $4.19 ($52,642)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-02-14 | Purchase | +10,000 | $4.18 | $41,800 | 5,185,786 | D: show line 1 in the form |
| Cambrian BioPharma Inc 10% owner | 2022-02-16 | Purchase | +2,551 | $4.25 | $10,842 | 5,188,337 | D: show line 2 in the form |
| Open-market purchases · 12,551 sh · avg $4.19 · $52,642 | |||||||
Loading xslF345X03/doc1.xml…